Sfoglia per Autore
Effects of high doses of corticosteroids on bone metabolism.
2002-01-01 P. ARDISSONE; E. ROTA; L. DURELLI; P. LIMONE; G.C. ISAIA
Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?
2002-01-01 E. VERDUN; G. ISOARDO; A.OGGERO; B. FERRERO; A. GHEZZI; E.MONTANARI; M. ZAFFARONI; L. DURELLI; THE BETAFERON SAFETY TRIAL BEST STUDY GROUP
Interferon beta-1a and beta-1b for treatment of multiple sclerosis
2002-01-01 KAPPOS L; BENATAR M; L. DURELLI
High-dose intravenous immunoglobulin G treatment of myasthenia gravis.
2002-01-01 FERRERO B ;DURELLI L
High-dose intravenous immunoglobulin treatment of multiple sclerosis.
2002-01-01 L. DURELLI; ISOARDO G
Brain volume changes in patients at presentation with suspected Multiple Sclerosis: results from the Etoms Study
2002-01-01 G. COMI; M. INGLESE; N. DE STEFANO; S. SMITH; F. BARKHOF; L. DURELLI; G. EDAN; O. FERNANDEZ; H.P. HARTUNG; P.M. MATTHEWS; P. SEELDRAYERS; P.S. SORENSEN; V. MARTINELLI; O.R. HOMMES; M. FILIPPI
Different pathogenesis of thalidomide neuropathy in multiple myeloma.
2002-01-01 G. ISOARDO; D. COCITO; P. BARBERO; M. BERGUI; P. CIARAMITARO; A. BERTOLA; M. BOCCADORO; B. BERGAMASCO; L. DURELLI
High-dose immunoglobulin treatment in neurological diseases.
2002-01-01 L. DURELLI; SUPPLEMENTUM EDITOR
Interferon beta-1a and beta-1b for treatment of multiple sclerosis. Author reply. PMID: 12424021 [PubMed - indexed for MEDLINE]
2002-01-01 DURELLI L
Different pathogenesis of thalidomide neuropathy in multiple myeloma.
2002-01-01 G. ISOARDO; D. COCITO; P. BARBERO; M. BERGUI; P. CIARAMITARO; A. BERTOLA; M. BOCCADORO; B. BERGAMASCO; L. DURELLI
Myasthenia gravis and tumour: a case-control study.
2002-01-01 A. CITTERIO; E. BEGHI; V. COSIA; A. EVOLI; L. DURELLI; G. PICCOLO; A. MILLUL
Autonomic function in different patterns of chronic inflammatory demyelinating polyneuropathy.
2002-01-01 D. COCITO; G. ISOARDO; P. CIARAMITARO; S. MAULE; R. QUADRI; B. BERGAMASCO; L. DURELLI
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
2002-01-01 L. DURELLI; E. VERDUN; P. BARBERO; M. BERGUI; E. VERSINO; A. GHEZZI; E. MONTANARI; M. ZAFFARONI
Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
2002-01-01 D. COCITO; P. CIARAMITARO; G. ISOARDO; P. BARBERO; G. MIGLIARETTI; A. PIPIERI; G. PROTO; R. QUADRI; B. BERGAMASCO; L. DURELLI
Is it possible to reduce the dose of interferon (IFN) beta in MS patients with a prolonged MRI-confirmed absence of disease activity?
2002-01-01 P. Barbero; A. Pipieri; E. Verdun; M. Bergui; G. Isoardo; A. Bosio; M. Clerico; A. Cucci; A. Ricci; B. Bergamasco; L. Durelli
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a
2003-01-01 BARKHOF F; ROCCA M; FRANCIS G; VAN WAESBERGHE JH; UITDEHAAG BM; HOMMES OR; HARTUNG HP; DURELLI L; EDAN G; FERNÁNDEZ O; SEELDRAYERS P; SØRENSEN P; MARGRIE S; ROVARIS M; COMI G; FILIPPI M
Reducing interferon beta dose in chronically-treated ms patients may have long-term deleterious effects on disease activity
2003-01-01 L. DURELLI; P.BARBERO; M.BERGUI; E. VERDUN; A.PIPIERI; M. CLERICO; B.BERGAMASCO
Evaluation of high-dose interferon beta-1b in relapsing-remitting ms non-responder patients: the optims trial. safety data.
2003-01-01 E.VERDUN; A. RICCI; M. CLERICO; P. BARBERO; M. IAMPAGLIA; L. DURELLI; AND THE OPTIMS TRIAL STUDY GROUP
Immunoglobulin treatment of multiple sclerosis: future prospects.
2003-01-01 DURELLI L ;RICCI A ;VERDUN E
Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia.
2003-01-01 D. COCITO; L. DURELLI; G. ISOARDO.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile